Literature DB >> 34435484

Not all mismatches are equal: importance of alloreactivity direction.

Jacinta Perram1, Nada Hamad2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 34435484      PMCID: PMC8968883          DOI: 10.3324/haematol.2021.279587

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

1.  Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.

Authors:  Robert Zeiser; Nikolas von Bubnoff; Jason Butler; Mohamad Mohty; Dietger Niederwieser; Reuven Or; Jeff Szer; Eva M Wagner; Tsila Zuckerman; Bruyère Mahuzier; Judith Xu; Celine Wilke; Kunal K Gandhi; Gérard Socié
Journal:  N Engl J Med       Date:  2020-04-22       Impact factor: 91.245

2.  Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial.

Authors:  Madan Jagasia; Miguel-Angel Perales; Mark A Schroeder; Haris Ali; Nirav N Shah; Yi-Bin Chen; Salman Fazal; Fitzroy W Dawkins; Michael C Arbushites; Chuan Tian; Laura Connelly-Smith; Michael D Howell; H Jean Khoury
Journal:  Blood       Date:  2020-05-14       Impact factor: 22.113

3.  Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Authors:  Katharina Fleischhauer; Bronwen E Shaw; Theodore Gooley; Mari Malkki; Peter Bardy; Jean-Denis Bignon; Valérie Dubois; Mary M Horowitz; J Alejandro Madrigal; Yasuo Morishima; Machteld Oudshoorn; Olle Ringden; Stephen Spellman; Andrea Velardi; Elisabetta Zino; Effie W Petersdorf
Journal:  Lancet Oncol       Date:  2012-02-15       Impact factor: 41.316

4.  ATG in allogeneic stem cell transplantation: standard of care in 2017? Point.

Authors:  Andrea Bacigalupo
Journal:  Blood Adv       Date:  2017-03-28

5.  Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation.

Authors:  Jun Zou; Stefan O Ciurea; Piyanuch Kongtim; Min Yi; Yudith Carmazzi; Gabriela Rondon; Samer Srour; David Partlow; Richard E Champlin; Kai Cao
Journal:  Blood Adv       Date:  2020-08-11

6.  Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.

Authors:  Robert Zeiser; Nicola Polverelli; Ron Ram; Shahrukh K Hashmi; Ronjon Chakraverty; Jan Moritz Middeke; Maurizio Musso; Sebastian Giebel; Ant Uzay; Peter Langmuir; Norbert Hollaender; Maanasa Gowda; Tommaso Stefanelli; Stephanie J Lee; Takanori Teshima; Franco Locatelli
Journal:  N Engl J Med       Date:  2021-07-15       Impact factor: 91.245

7.  The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation.

Authors:  Pietro Crivello; Laura Zito; Federico Sizzano; Elisabetta Zino; Martin Maiers; Arend Mulder; Cristina Toffalori; Luigi Naldini; Fabio Ciceri; Luca Vago; Katharina Fleischhauer
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-23       Impact factor: 5.742

8.  Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.

Authors:  Jun Zou; Piyanuch Kongtim; Betül Oran; Vasilis Kosmoliaptsis; Yudith Carmazzi; Junsheng Ma; Liang Li; Gabriela Rondon; Samer Srour; Hannah C Copley; David Partlow; Stefan O Ciurea; Uri Greenbaum; Qing Ma; Elizabeth J Shpall; Richard E Champlin; Kai Cao
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 9.941

9.  A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation.

Authors:  Elisabetta Zino; Guido Frumento; Sarah Marktel; Maria Pia Sormani; Francesca Ficara; Simona Di Terlizzi; Anna Maria Parodi; Ruhena Sergeant; Miryam Martinetti; Andrea Bontadini; Francesca Bonifazi; Daniela Lisini; Benedetta Mazzi; Silvano Rossini; Paolo Servida; Fabio Ciceri; Chiara Bonini; Edoardo Lanino; Giuseppe Bandini; Franco Locatelli; Jane Apperley; Andrea Bacigalupo; Giovanni Battista Ferrara; Claudio Bordignon; Katharina Fleischhauer
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.